286 studies found for:    "Treatment Naive" [CONDITION] AND HIV [CONDITION]
Show Display Options
Download search resultsDownload the search results for:
"Treatment Naive" [CONDITION] AND HIV [CONDITION] (286 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Intensive Viral Dynamics Substudy of A5248
Conditions: HIV Infections;   Treatment Naive
Intervention:
2 Completed Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Conditions: HIV Infections;   Treatment Naive
Intervention:
3 Completed
Has Results
Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: Stribild;   Drug: Atripla
4 Completed
Has Results
A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients
Condition: Human Immunodeficiency Virus Type 1
Interventions: Drug: TMC310911 75 mg twice daily;   Drug: TMC310911 150 mg twice daily;   Drug: TMC310911 300 mg twice daily;   Drug: TMC310911 300 mg once daily;   Drug: Ritonavir 100 mg twice daily;   Drug: Ritonavir 100 mg once daily
5 Completed Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761;   Drug: Lopinavir/ritonavir;   Drug: HAART;   Drug: Placebo
6 Completed
Has Results
Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)
Condition: HIV Infections
Interventions: Drug: Atazanavir + 2 NRTIs;   Drug: Atazanavir + Ritonavir + 2 NRTIs
7 Completed
Has Results
"The Once A Day Protease Inhibitor Regimens"
Condition: HIV Infections
Interventions: Drug: ritonavir-boosted atazanavir;   Drug: ritonavir-boosted fosamprenavir
8 Completed HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)
Conditions: HIV-Associated Lipodystrophy Syndrome;   Cardiovascular Disease
Interventions: Drug: Lamivudine;   Drug: Stavudine;   Drug: Didanosine;   Drug: Zidovudine;   Drug: Tenofovir;   Drug: Abacavir;   Drug: Efavirenz (EFV);   Drug: Nevirapine;   Drug: Indinavir;   Drug: Saquinavir;   Drug: Amprenavir;   Drug: Ritonavir;   Drug: Nelfinavir;   Drug: Tipranavir;   Drug: enfuvirtide (T20)
9 Unknown  Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients
Condition: HIV-Associated Lipodystrophy Syndrome
Intervention: Drug: nucleoside analogue sparing HAART regimen
10 Active, not recruiting Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Intervention: Drug: E/C/F/TAF
11 Unknown  Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya
Conditions: HIV Infections;   Human Immunodeficiency Virus;   Malaria;   Plasmodium Falciparum;   Diarrhea
Intervention: Other: Bednets and Water Purification
12 Recruiting Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Drug: EVG/COBI/FTC/TDF
13 Completed Safety and Efficacy of Darunavir/Cobicistat/Emtricitabine/GS-7340 Single Tablet Regimen Versus Cobicistat-boosted Darunavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate Fixed Dose Combination in HIV-1 Infected, Antiretroviral Treatment Naive Adults
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: D/C/F/TAF;   Drug: DRV;   Drug: COBI;   Drug: FTC/TDF;   Drug: Placebo to match D/C/F/TAF;   Drug: Placebo to match DRV;   Drug: Placebo to match COBI;   Drug: Placebo to match FTC/TDF
14 Active, not recruiting Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/GS-7340 Single Tablet Regimen Versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen in HIV 1 Infected, Antiretroviral Treatment-Naive Adults
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: Placebo to match E/C/F/TAF;   Drug: Placebo to match E/C/F/TDF
15 Active, not recruiting Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women (WAVES)
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: EVG/COBI/FTC/TDF;   Drug: RTV;   Drug: ATV;   Drug: FTC/TDF;   Drug: EVG/COBI/FTC/TDF Placebo;   Drug: RTV Placebo;   Drug: ATV Placebo;   Drug: FTC/TDF Placebo
16 Completed
Has Results
A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients
Conditions: HIV Infection;   HIV;   Acquired Immunodeficiency Syndrome
Interventions: Drug: etravirine (ETR, TMC125);   Drug: efavirenz (EFV)
17 Active, not recruiting Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: Cobicistat;   Drug: Darunavir;   Drug: NRTI
18 Completed
Has Results
TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.
Conditions: HIV Infections;   HIV-1;   Human Immunodeficiency Virus Type 1
Interventions: Drug: TMC278;   Drug: efavirenz
19 Completed
Has Results
Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission
Conditions: Disease Transmission, Vertical;   Vertical Human Immunodeficiency Virus Transmission;   HIV Infections
Interventions: Drug: Zidovudine;   Drug: Nevirapine (NVP);   Drug: Epivir (3TC);   Drug: Nelfinavir (NFV)
20 Completed Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection;   HIV-1 Infection
Interventions: Procedure: Cheek cells sample;   Procedure: Blood sample

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years